Found 10 matching trials
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis PHASE2 This is a single-center, single-arm, open-label study that includes patient...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College
Learn More & Join Trial
MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer NA This is an investigator-initiated, prospective, national multi-center, phas...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability NA Our objective is based on a personalized approach of adjuvant breast radiot...
Show More Location
Institut Du Cancer de Montpellier
Learn More & Join Trial
Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt NA Technical advances in radiotherapy (RT) treatment planning and delivery hav...
Show More Location
Medical Center - University of Freiburg
Learn More & Join Trial
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NA Study Overview This research compares two types of post-operative salvage r...
Show More Location
Gatineau Hospital
Learn More & Join Trial
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer NA To evaluate the safety, tolerability, and preliminary efficacy of moderatel...
Show More Location
Rutgers Cancer Institut Jersey
Learn More & Join Trial
Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer NA The aim of the study is
1. Statistical evaluation of patients' characteris...
Show More Learn More & Join Trial
Microbiota-guided Radiotherapy for Head and Neck Cancer N/A Head and neck cancer (HNC) is the sixth most common cancer worldwide. Thera...
Show More Location
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Learn More & Join Trial
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis PHASE2 This is a single-center, single-arm, open-label study that includes patient...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College
Learn More & Join Trial
5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics NA This is a prospective, randomized, single-center, non-inferiority intervent...
Show More Location
IRCCS San Raffaele Scientific Institute
Learn More & Join Trial